The press release here;
http://www.beverleyguardian.co.uk/news/health/stem-cell-stroke-treatment-trial-results-show-promise-1-5718066
The trial itself here;
Pilot Investigation of Stem Cells in Stroke (PISCES)
Purpose
The
study is designed to test the safety of a manufactured neural stem cell
line (CTX cells) delivered by injection into the damaged brains of male
patients 60 years of age or over who remain moderately to severely
disabled 6 months to 5 years following an ischemic stroke. In addition
the trial will evaluate a range of potential efficacy measures for
future trials. Treatment will involve a single injection of one of four
doses of CTX cells into the patient's brain in a carefully controlled
neurosurgical operation performed under general anesthetic. The trial is
designed to treat 12 patients and measure outcomes over 24 months.
Patients will be invited to participate in a long-term follow-up trial
for a further 8 years.
No comments:
Post a Comment